Start-up company opens first US office

NeoPrediX starts marketing its prediction software platform in USA

Launching first in the U.S.: NeoPrediX brings prediction software for neonatal and preterm care units to market. www.neopredix.com

November 15, 2021 - With the establishment of NeoPrediX USA in Fort Lauderdale (Florida) the German/Swiss NeoPredix AG starts its US business and pushes its internationalization strategy. The start-up company develops prediction software for hospitals and neonatal units based on scientific and clinical data as well as science-based algorithms.

Breakthrough prediction software for newborns

"Starting from November 2021, hospitals, physicians and nurses in the U.S. will be able to access our newly developed prediction software platform. Individual disease risks for infants can be predicted for the first time by our software solution. This way we support medical staff in their therapeutic decision making and can aid in avoiding long-term complications for the most vulnerable patients - the newborns" underlines CEO Thorsten Waloschek the potential of the innovation.  

The new healthcare solution was developed by renowned scientists, pediatricians and neonatologists in close cooperation with universities and hospitals. The certified software platform will be available in the USA as early as November. From then on, doctors, nurses and hospitals will be able to use the world’s first bilirubin prediction operating system and digitally integrate it into their analysis processes.